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shows various clinical conditions, such as fever, malaise, systemic lymphadenopathy, and multiple organ failure 1 . It also indicates various laboratory abnormalities, such as hypergammaglobulinemia, thrombocytosis, anemia, and elevation of C-reactive protein levels 1 .
It is well-known that Human herpes virus-8 (HHV-8)-related MCD occur mainly in patients suffering from human immunodeficiency virus (HIV) infection. However, idiopathic MCD (iMCD) cases with HIV-negative and HHV-8-negative have been reported in Japan [2] [3] [4] .
In addition, Fajgenbaum et al. 5 have recently described the presence of HIV-negative and HHV-8-negative iMCD in Western countries. They classified iMCD into three types based on histopathology: (i) plasmacytic (PC), (ii) mixed, and (iii) hypervascular (hyperV).
In 2010, the report from Takai et al. 6 showed three cases termed TAFRO syndrome A C C E P T E D M A N U S C R I P T displaying several common clinical symptoms, such as thrombocytopenia, anasarca, fever, renal failure or reticulin fibrosis, and organomegaly. The lymph node (LN) obtained from the TAFRO syndrome patients was histopathologically similar to hyaline-vascular type of CD, but they were clinically quite different from typical iMCD. Despite these findings, Fajgenbaum, et al. 5 later classified this characteristic syndrome as one phenotype type for MCD according to the histopathological similarity of LN lesions in iMCD.
In our previous report 7 , a clinicopathological analysis was performed on 70 nodal cases of iMCD with/without TAFRO. The tissue of LN in PC-type histopathologically showed a characteristically atrophic lymphoid follicle (LF) and mild vascular proliferation at the germinal center (GC). Also, at the interfollicular area, a sheet-like infiltration of plasma cells was observed but vascular proliferation was very sparsely seen. In the mixed-type, atrophic to hyperplastic LF was formed, and glomeruloid vascular proliferation (GVP) was found in GCs.
A dense proliferation of high endothelial venules without hyalinization was recognized in the interfollicular region, and plasma cell infiltration was observed around the blood vessels. A marked atrophic change of LF was observed in hyperV-type, and GVP completely replaced with GC. Furthermore, we revealed markedly high endothelial venules at the interfollicular area, and that plasma cell infiltration was found sparsely.
To clarify the clinicopathological findings of iMCD with/without TAFRO, it is necessary to observe systemic histopathological changes in not only lymph node tissue but also in other All tissue samples were embedded in paraffin after 10% neutral buffered formalin fixation. The sections were stained with hematoxylin and eosin (H&E), Gitter stain to evaluate the fibrosis grade, and periodic acid-methenamine silver stain (PAM) to evaluate renal lesions.
The degree of reticulin fibrosis was evaluated according to the myelofibrosis grading system proposed by Thiele et al. 10 . All bone marrow cases were evaluated by needle biopsy specimen. Standard 4 µm-thick sections were cut from all samples. Immunostaining was
automatically (BenchMark GX, Ventana Medical System, Tucson, AZ, USA), and the antigenantibody complex was visualized with 3,3'-diaminobenzidine solution. An anti-human IL-6 monoclonal antibody (clone 10C12, 1:50 dilution; Leica Microsystems, Wrtzlar, Germany) was immunostained with incubation for 30 min at 37 °C [11] [12] [13] [14] [15] . Immunostaining for IL-6 was evaluated only in kidney specimens.
PRISM software program, ver. 6 (Graph Pad Software, La Jolla, CA, USA) was used for all statistical analyses. The Mann-Whitney U test was used to compare histopathological data among iMCD with/without TAFRO. P < 0.05 was considered to be significant [11] [12] [13] [14] [15] .
RESULTS
After excluding patients with the diseases described in the exclusion criteria, a total of 70 iMCD cases, including 37 with TAFRO and 33 without TAFRO cases, were ultimately selected.
Among these 70 cases, we examined extranodal histopathological changes present in kidney (n = 2), bone marrow (n = 17), lung (n = 5), skin (n = 3), and thymus (n = 2). The number of each organs were summarized in Table 1 .
Extranodal lesions
Kidney Renal biopsy specimens from two patients with iMCD with TAFRO (one PC-type and one mixed-type) were evaluated. Both cases showed histopathological changes indicative of membranoproliferative glomerulonephritis (MPGN). The glomeruli showed lobular architectures with increased numbers of mesangial cells and mesangial matrix ( Fig. 1A) . At the periphery of the glomerulus, a double contour was observed ( Fig. 1B) . No proliferation of vascular endothelial cells was noted. Immunohistochemical staining for IL-6 revealed positivity for proliferated mesangial cells, visceral epithelial cells, Bowman's epithelial cells and tubular epithelial cells (Fig. 1C ). The number of mesangial cells per glomerulus in iMCD with TAFRO was significantly higher than in normal kidney control (76.5 ± 13.0 versus 36.0 ± 9.39, P < .0001).
Bone marrow
Bone marrow biopsy specimens from patients with iMCD with TAFRO (PC-type; n = 1, mixed-type; n = 13) and iMCD without TAFRO (PC-type; n = 2, mixed-type; n = 1) were evaluated. The cellularity of iMCD with TAFRO was variable; hypocellular (n = 1), normocellular (n = 9), or hypercellular (n = 4, Fig. 2A ). The cellularity of iMCD without TAFRO was normocellular (n = 2) and hypercellular (n = 1). The number of megakaryocytes/HPF was not significantly different between iMCD with TAFRO (10.9 ± 10.0) and iMCD without TAFRO (8.7 ± 9.8). Atypical megakaryocytes were found in 50% of the iMCD with TAFRO cases and 33.3% of the iMCD without TAFRO cases (Fig. 2B) . The fibrosis grade of iMCD with TAFRO was MF0 (n = 3), MF1 (n = 7), and MF2 (n = 4), while that of iMCD without TAFRO was MF0 (n = 3). The fibrosis grade in iMCD with TAFRO was significantly higher than in iMCD without TAFRO (P = 0.0256). Plasmacytosis was found both iMCD with TAFRO and iMCD without TAFRO.
Lung
Lung biopsy specimens from five patients with PC-type iMCD without TAFRO were evaluated. Peribronchial and periarterial chronic inflammation accompanied by the formation of LFs was observed (Fig. 3A) . In some areas, nodular stromal fibrosis with lymphocyte Interestingly, the renal lesions associated with iMCD with TAFRO showed histopathological findings of MPGN. Zhang et al. 16 reported two cases of iMCD showing MPGN, but neither met the diagnostic criteria for TAFRO syndrome. In contrast, Tanaka et al. 17 reported MPGN-like lesions complicated with TAFRO syndrome with serum IL-6, VEGF, and Cre elevation. Noda-Narita et al. 18 also showed diffuse lobular endocapillary proliferative glomerulonephritis with endothelial swelling and the infiltration of monocytes and neutrophils.
Similarly, Ozeki et al. 19 revealed thrombotic microangiopathy-like lesions with lobular pattern, mesangiolysis, double contours of the glomerular basement membranes and marked endothelial swelling. We showed for the first time that mesangial cells are positive for IL-6 immunostaining in renal lesions associated with TAFRO syndrome. Matsumura 20 examined distribution of IL-6 in human proliferative glomerulonephritis, immunohistochemically. IL-6 is localized in the mesangial region, visceral epithelial cells, Bowman's epithelial cells, cellular crescent and tubular epithelial cells. Furthermore, IL-6 plays a role as an autocrine regulator of mesangial cell proliferation, and expression of IL-6 has been shown to be a good indicator of glomerular cell proliferation [21] [22] . The proliferation of mesangial cells accompanied by the high expression of IL-6 was presumed to cause secondary Audia et al. 23 showed that splenic macrophages phagocytosed platelets with the production of antiplatelet antibodies, resulting in thrombocytopenia. Even in the presence of TAFRO syndrome, the production of platelet-associated IgG has been reported 24 , which is presumed to cause hypersplenism and thrombocytopenia. Increases in the numbers of atypical megakaryocytes and reticulum fibers are thought to be reactive changes accompanying thrombocytopenia. In the present study, we observed cases in which reticulin fibrosis was not noticeable in the bone marrow of patients with TAFRO syndrome. Therefore, we should consider not only the presence of reticular fibrosis but also increases in the numbers of megakaryocytes and nuclear atypia as the features of TAFRO syndrome.
No pulmonary lesions were examined in cases of iMCD with TAFRO in this study. In some cases of iMCD without TAFRO, characteristic pulmonary lesions, such as lymphoplasmacytic proliferation mainly in the alveolar area adjacent to the perilymphatic 
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